Financial News

AbbVie (NY:ABBV)

189.83 +2.36 (+1.26%)

Official Closing Price Updated: 7:00 PM EDT, Jun 6, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

80 81 Next >

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years

February 28, 2024

Via Benzinga

Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea

February 27, 2024

From Healis Therapeutics

Via GlobeNewswire

3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade

February 27, 2024

These stocks don't offer the highest yields, but their payouts are growing fast.

Via The Motley Fool

Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?

February 26, 2024

FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.

Via Benzinga

3 Dividend Stocks That Are No-Brainer Buys Right Now

February 24, 2024

These stocks check off multiple boxes for investors.

Via The Motley Fool

AbbVie Inc. (NYSE: ABBV) Records 52-Week High Friday Morning

February 16, 2024

Via Investor Brand Network

AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating

February 14, 2024

A Relative Strength Rating upgrade for AbbVie shows improving technical performance.

Via Investor's Business Daily

AbbVie Options Trading: A Deep Dive into Market Sentiment

February 07, 2024

Via Benzinga

Is AbbVie Stock a Buy Now?

February 22, 2024

Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.

Via The Motley Fool

5 Forever Dividend Stocks to Build Your Portfolio

February 20, 2024

These five stocks are high quality and reliable.

Via The Motley Fool

3 Magnificent Growth Stocks to Buy Right Now

February 19, 2024

These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.

Via The Motley Fool

3 Cash Cows to Boost Your Confidence During the February Chill

February 18, 2024

The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.

Via InvestorPlace

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

February 15, 2024

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END

Via FinancialNewsMedia

AbbVie Inc. (NYSE: ABBV) Records 52-Week High Wednesday Morning

February 07, 2024

Via Investor Brand Network

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

February 15, 2024

From FN Media Group LLC

Via GlobeNewswire

Beyond Nvidia: How To Navigate Investing In Your 40s — Insights From Reddit

February 14, 2024

A Reddit user reached out to the community seeking advice beyond the hunt for the "next NVIDIA Corp." Here's a sample of the responses.

Via Benzinga

$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today

February 06, 2024

Via Benzinga

2 Magnificent Dividend Growth Stocks to Load Up On Right Now

February 06, 2024

These two dividend-growth stocks are fantastic buys.

Via The Motley Fool

The 7 Best Momentum Stocks You Can Purchase Today

February 12, 2024

If you’re looking for hot opportunities in the market, here are just a few of the best momentum stocks to buy today.

Via InvestorPlace

Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?

February 12, 2024

These incredible businesses have long histories of successes behind them, and more to come.

Via The Motley Fool

These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy

February 11, 2024

The drugmaker is handling its biggest obstacle yet relatively well.

Via The Motley Fool

Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'

February 09, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all...

Via Benzinga

3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying?

February 08, 2024

Letting your winners run is a proven way to generate extraordinary portfolio returns without cutting them off by taking profits.

Via InvestorPlace

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List

February 06, 2024

These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.

Via InvestorPlace

7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024

February 06, 2024

Unveil these standout Russell 2000 stocks, meticulously picked to harness the potential of the evolving market landscape in the 2024 surge.

Via InvestorPlace

UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst

February 06, 2024

UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.

Via Benzinga

7 Dividend Stocks Worth Holding for the Long Haul

February 06, 2024

These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly.

Via InvestorPlace

Why AbbVie Stock Flew Higher on Monday

February 05, 2024

Investors and pundits alike continued to be impressed by the company's latest earnings report.

Via The Motley Fool

Drug Maker AbbVie Stock Sees RS Rating Jump To 81

February 05, 2024

AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81.

Via Investor's Business Daily

Better Dividend Stock: Pfizer vs. AbbVie

February 05, 2024

Both offer above-average yields but which can deliver the most dividend income over the long run?

Via The Motley Fool

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

80 81 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Financial News

AbbVie (NY:ABBV)

All News about AbbVie

Popular Pages